996热re视频精品视频这里,国产又色又爽又高潮免费,精品自拍亚洲一区在线,久久久综合九色合综,国产精品亚洲综合一区在线观看

Lactoferricin B (4-14) (bovine)

Category:Active Pharmaceutical Ingredients > Biochemical Ingredients > Peptides
Product Name:Lactoferricin B (4-14) (bovine)
CAS No.:183476-25-7
Standard:In-house Standards
Price(USD):Negotiable
Company:Hangzhou Go Top Peptide Biotech Co.,Ltd.

Basic Info
  • Grade: Research grade

    Factory Location: Hangzhou

    Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe, Australasia,Asia,Middle East,Africa

  • Monthly Production Capacity: hundreds of grams

    Packaging Information: 500mg,1g, 10g,50g 100g?per?package with icebag

  • Delivery Lead Time: In stock or 2-3weeks

    Sample Provided: yes

    Payment Terms: T/T

    Lactoferricin B (LfcinB for short) is a class of small-molecule antibacterial peptides containing tryptophan, which is produced by the hydrolysis of bovine lactoferrin (bLf) in the digestive tract by pepsin. Like other antimicrobial peptides, Lactoferricin B has a broad-spectrum bactericidal activity. In addition, it may also have a variety of biological functions such as inhibiting the proliferation of viruses and fungi, inhibiting tumor cells, and almost no toxicity to eukaryotic cells. Based on this selective effect and non-antigenic characteristics, Lactoferricin B is expected to become a new generation of new antibacterial, antiviral and antitumor drugs. Lactoferricin B (4-14) (bovine) is a peptide fragment composed of 11 amino acids in Lactoferricin B, which has good antibacterial activity.
Send your message to this supplier
  • From:
  • To:
    Hangzhou Go Top Peptide Biotech Co.,Ltd.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    -?Supports?jpg,?jpeg,?png,
    ?gif,?pdf,?doc,?docx,
    ?xls,?xlsx,?txt,?rar?and?zip
    -?Max?upload?3?files;
    ?Max??total?size:?3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service